Cellosaurus logo
expasy logo

Cellosaurus PAX-C003 (CVCL_D7E0)

[Text version]
Cell line name PAX-C003
Synonyms PAXC003
Accession CVCL_D7E0
Resource Identification Initiative To cite this cell line use: PAX-C003 (RRID:CVCL_D7E0)
Comments Group: Patented cell line.
Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201007.
Population: Chinese.
Characteristics: Established from a xenograft produced by subcutaneous injection of tumor cells into SCID mice (PubMed=22076649).
Doubling time: 33.79 hours (Patent=CN102250840B); ~34 hours (PubMed=22076649).
Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
Disease Pancreatic ductal adenocarcinoma (NCIt: C9120)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 62Y
Category Cancer cell line
STR profile Source(s): PubMed=22325559

Markers:
AmelogeninX,Y
CSF1PO10,12
D5S81812,13
D7S82011,12
D13S31710
D16S53912,13
TH019
TPOX8,11
vWA16

Run an STR similarity search on this cell line
Publications

PubMed=22076649; DOI=10.3892/ijo.2011.1254
Hu G., Li F., Ouyang K.-D., Xie F.-B., Tang X.-Z., Wang K., Han S.-F., Jiang Z.-Z., Zhu M.-H., Wen D.-Y., Qin X.-R., Zhang L.-Y.
Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
Int. J. Oncol. 40:798-806(2012)

PubMed=22325559; DOI=10.1111/j.1742-4658.2012.08521.x
Li F., Hu G., Jiang Z.-Z., Guo J., Wang K., Ouyang K.-D., Wen D.-Y., Zhu M.-H., Liang J.-X., Qin X.-R., Zhang L.-Y.
Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells.
FEBS J. 279:1261-1273(2012)

Patent=CN102250840B
Wen D.-Y., Qin X.-R., Hu G., Ouyang K.-D., Zhu M.-H., Xie F.-B.
Human pancreatic cancer cell line and its application.
Patent number CN102250840B, 18-Jun-2014

Cross-references
Cell line databases/resources CCRID; 4201PAT-CCTCC00329
Entry history
Entry creation10-Sep-2024
Last entry update10-Sep-2024
Version number1